The NCI-MATCH precision medicine cancer clinical trial is expanding with the opening of a new treatment arm, expanding patients' potential to qualify for the trial when they may not have other options. The largest precision medicine cancer clinical trial to date is NCI-MATCH with 39 single-arm phase II treatment arms. Researchers are locating patients for the 12 remaining arms as the results are published or being analyzed for the other arms.
Idaho National Laboratory tested how small hydropower plants can serve as reliable sources of startup power during outages.
The UK Markey Cancer Center will be the first site worldwide to initiate a cancer clinical trial that evaluates its anti-cancer activity in humans using ArtemiLife™ Inc. coffee products, which are made using the leaves of the Artemisia annua plant.
Wolters Kluwer, Health announced today the addition of two fully open access journals to the Lippincott® portfolio as part of a shared mission with Shandong University to expand the reach of healthcare discoveries globally with the publication of Emergency and Critical Care Medicine and Current Urology. The new open access titles publish original research in their respective medical specialties.
The 2Exciting network (GA No 956813), coordinated by Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, Germany, aims to develop the next generation of scientists with high level skills and understanding of the rapidly evolving field of nano - optoelectronics, the study and applications of electronic devices that interact with light in 2D materials, specifically, semiconductors. The goal of 2Exciting is training early career researchers in an unmatched combination of scientific and complementary skills.
As part of an effort to help address America's and the world's needs for clean energy, the Wright Center for Photovoltaics at The University of Toledo (UToledo), Colorado State University (CSU) and the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) have teamed with U.S.-based companies to form the U.S. Manufacturing of Advanced Cadmium Telluride (US-MAC) photovoltaics consortium.
New Israeli research is being conducted to develop a hypoxia radioactive marker (a phenomenon of lack of oxygen in cells) based on the Copper 64 isotope to identify oxygen-deficient cells. The hypoxia radioactive marker will determine if a tumor is malignant or benign, as well as how aggressive it is, through a single image -- eliminating the need for a biopsy.
On January 27, President Joe Biden signed an executive order to tackle climate challenges at home and abroad, which both elevates and frames climate concerns within a national security perspective. Responding swiftly, the Naval Postgraduate School (NPS) launched the Climate and Security Network, connecting NPS faculty with relevant expertise across campus together, along with staff, students and even alumni, ready to collaborate on important research and support related educational efforts.